[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369324-105":59,"doc-detail-369324-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-olfactory-receptor-or51e2-regulates-prostate-cancer-aggressiveness-and-modulates-stat3-in-prostate-cancer-cells-and-in-xenograft-tumors","The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors","","Despite advances in detecting and treating prostate cancer, the molecular drivers of disease progression remain unclear. This open-access study examines OR51E2, a receptor frequently upregulated in prostate cancer, and tests whether it controls tumor aggressiveness and STAT3-associated signaling. Using CRISPR-Cas9 monoclonal OR51E2 knockout plus transcriptomic and proteomic profiling in xenograft models, the study links OR51E2 loss to enhanced malignant phenotypes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-olfactory-receptor-or51e2-regulates-prostate-cancer-aggressiveness-and-modulates-stat3-in-prostate-cancer-cells-and-in-xenograft-tumors/369324/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-olfactory-receptor-or51e2-regulates-prostate-cancer-aggressiveness-and-modulates-stat3-in-prostate-cancer-cells-and-in-xenograft-tumors/369324.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on OR51E2 in prostate cancer?","Question",{"text":112,"@type":113},"To determine how the olfactory receptor OR51E2, commonly upregulated in prostate cancer, contributes to disease progression and whether it modulates STAT3-related processes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was OR51E2 function tested in this research?",{"text":117,"@type":113},"The study used CRISPR-Cas9-induced monoclonal OR51E2 knockout and evaluated tumorigenicity in vitro and in vivo, followed by transcriptomic and proteomic analyses of xenograft tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about OR51E2 knockout cells?",{"text":121,"@type":113},"OR51E2-knockout cells showed increased proliferation, migration, adhesion, anchorage-independent colony formation, and higher tumor growth rates, indicating a more aggressive phenotype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369324,1790196431,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Thomsen et al. BMC Cancer (2025) 25:535 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-13928-0](https://doi.org/10.1186/s12885-025-13928-0)  \nRESEARCH Open Access  \nThe olfactory receptor OR51E2 regulates  prostate cancer aggressiveness  \nand modulates STAT3 in prostate cancer cells and in xenograft tumors  \nMikkel Thy Thomsen 1,2*, Morten Busk3,4, Dalin Zhang2, Chun-Lung Chiu2, Hongjuan Zhao2, Fernando Jose GarciaMarques5, Abel Bermudez5, Sharon Pitteri5, Michael Borre6,7, James D. Brooks2 and Jens Randel Nyengaard 1,8  \nAbstract  \nBackground Despite advancements in the detection and treatment of prostate cancer, the molecular mechanisms underlying its progression remain unclear. This study aimed to investigate the role of the receptor OR51E2, which is commonly upregulated in prostate cancer, in the progression of this disease.  \nMethods We investigated the physiological effects of OR51E2 through CRISPR-Cas9-induced monoclonal OR51E2 knockout. We assessed in vitro and in vivo tumorigenicity and conducted transcriptomic and proteomic analyses of xenograft tumors derived from these knockout cells. Furthermore, we analyzed the effects of differences in OR51E2-expression levels in patients from aTCGA cohort.  \nResults OR51E2-knockout cells exhibited increased proliferation, migration, adhesion, anchorage-independent colony formation, and tumor growth rates, resulting in a more aggressive cancer phenotype. Omics analyses revealed several potential pathways associated with significant molecular changes, notably an aberration in the STAT3 pathway linked to IL-6 signaling, highlighting a connection to inflammatory pathways. TCGA cohort analysis revealed that prostate cancer patients with low tumor OR51E2 expression had a worse prognosis and a higher average Gleason grade than those with higher expression levels. Additionally, this analysis supported the putative OR51E2-related modulation of the STAT3 pathway.  \nConclusions OR51E2 is regulated throughout prostate cancer progression and actively influences cancer cell physiology affecting cancer aggressiveness. Reduced OR51E2 expression may adversely affect patient outcomes, potentially through alterations in the STAT3 pathway that impact cellular responses to inflammatory signaling. Keywords Prostate cancer progression, Cancer physiology, Transcriptomics, Proteomics, Cell signaling, GPCR  \n*Correspondence:  \nMikkel Thy Thomsen [Mikkel.thomsen@cl in.au.dk](Mikkel.thomsen@cl in.au.dk)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nThomsen et al. BMC Cancer (2025) 25:535  \nBackground  \nProstate cancer is a growing health challenge worldwide and with 1 in 8 men predicted to receive the diagnosis throughout their lifetime, prostate cancer is the second most common noncutaneous cancer in men [1]. In recent decades, both the detection and treatment of prostate cancer have improved substantially [2], ","cbCaim0lXHkceJWz","https://ap.wps.com/l/cbCaim0lXHkceJWz","pdf",4057226,17,"English","# Background\n## Methods\n## Results\n## Conclusions\n# Keywords","[{\"question\":\"What is the main goal of the study on OR51E2 in prostate cancer?\",\"answer\":\"To determine how the olfactory receptor OR51E2, commonly upregulated in prostate cancer, contributes to disease progression and whether it modulates STAT3-related processes.\"},{\"question\":\"How was OR51E2 function tested in this research?\",\"answer\":\"The study used CRISPR-Cas9-induced monoclonal OR51E2 knockout and evaluated tumorigenicity in vitro and in vivo, followed by transcriptomic and proteomic analyses of xenograft tumors.\"},{\"question\":\"What did the results show about OR51E2 knockout cells?\",\"answer\":\"OR51E2-knockout cells showed increased proliferation, migration, adhesion, anchorage-independent colony formation, and higher tumor growth rates, indicating a more aggressive phenotype.\"}]","The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors | PDF",1790182052,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2a704969bd407bbb8f2a05e781ccc4f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d78ff4eb9de5e0665ed4a56fde4840c4.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36b664859d91f878421aae7968463781.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb37e7d227c9040774cd0e56220c1195.webp",980,1306]